The Principal Biostatistician will serve as study statistician or support statistician on Bronchiectasis or Hepatitis B programs. TA experience is an advantage but not essential. Primary Responsibilities: Responsible for protocol development including study design, sample size
Senior Statistician | Global CRO | UK | Remote | Permanent An exciting opportunity for an experienced Senior Statistician to join a well-established global CRO, supporting leading pharmaceutical and biotechnology clients across international clinical development programmes.
About the Company Our client is a respected membership organisation representing a major UK industrial sector. About the Role An exciting opportunity has arisen for an experienced data and insights professional to take ownership of a long-established
KAI Conversations is an AI-powered conversation analytics platform used by some of the worlds largest pharmaceutical companies to improve the quality and effectiveness of their customer interactions. The KAI platform supports multiple languages, integrates with enterprise
Clinical trials are high stakes, demanding high standards. Veramed sets this standard by bringing together the sharpest minds in data management, biostatistics and programming, with cutting-edge technology and proven processes. Our globally connected, caring team delivers quality,
Senior Director, Global Biometrics | Global Pharma| Hybrid | UK / France | Permanent An exciting opportunity has arisen for an experienced Senior Director, Biometrics to join a global, innovation-led pharmaceutical company at a pivotal stage
Freelance Statistician | Indirect Treatment Comparisons | Network Meta Analysis | HTA | UK Based | Outside IR35 | £35-£45 Per/Hour | 40 hours per week | 6 month contract | ASAP Start We are partnering with
Senior Statistician | UK | Remote | Mid-Size CRO | Permanent Our client is an established specialist biometrics consultancy providing high-quality statistical and programming services to the pharmaceutical and biotechnology industry. Due to continued growth, they are